Q3 2023 Holdings
Filed 2023-11-14 | 18 holdings | $151.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $32.1M | 2,106,000 | 21.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $27.5M | 2,404,614 | 18.2% |
| Merus N V | COM | N5749R100 | $27.1M | 1,150,225 | 17.9% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $14.8M | 994,161 | 9.8% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $13.4M | 5,224,600 | 8.8% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $11.1M | 1,103,178 | 7.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $6.7M | 1,710,154 | 4.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $3.2M | 1,363,025 | 2.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $2.9M | 9,775,849 | 1.9% |
| Kinnate Biopharma Inc | COM | 49705R105 | $2.8M | 1,997,006 | 1.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.3M | 235,787 | 1.5% |
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $2.2M | 815,512 | 1.5% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $1.9M | 1,019,230 | 1.3% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $1.9M | 702,415 | 1.2% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.1M | 1,766,815 | 0.7% |
| Passage BIO Inc | COM | 702712100 | $125.1K | 190,124 | 0.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $65.5K | 9,917 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $24.8K | 18,265 | 0.0% |